Flu virus infection is a common cause of acute respiratory illness, with the major incidence in pediatric age, high morbidity, and mortality. The flu vaccine is recommended for all people aged ≥6 months, unless specific contraindications are present. Younger and older age, pregnancy, chronic diseases like asthma, and immunodeficiency are risk factors for severe complications following flu infection. Thus, these categories represent the target for flu vaccine strategies in most countries. Inactivated influenza vaccine (IIV), recombinant influenza vaccine (RIV) or live-attenuated influenza virus (LAIV) are currently available, with specific precautions and contraindications. We aim to resume the current indications for vaccines in the vulnerable populations to support flu vaccination inclusiveness, in anticipation of a "universal vaccine" strategy.

Sgrulletti, M., Ottaviano, G., Sangerardi, M., Chini, L., Dellepiane, R.m., Martire, B., et al. (2020). One step closer to influenza vaccine inclusiveness. PEDIATRIC ALLERGY AND IMMUNOLOGY, 31(S26), 69-71 [10.1111/pai.13338].

One step closer to influenza vaccine inclusiveness

Chini, Loredana;Moschese, Viviana
2020-11-01

Abstract

Flu virus infection is a common cause of acute respiratory illness, with the major incidence in pediatric age, high morbidity, and mortality. The flu vaccine is recommended for all people aged ≥6 months, unless specific contraindications are present. Younger and older age, pregnancy, chronic diseases like asthma, and immunodeficiency are risk factors for severe complications following flu infection. Thus, these categories represent the target for flu vaccine strategies in most countries. Inactivated influenza vaccine (IIV), recombinant influenza vaccine (RIV) or live-attenuated influenza virus (LAIV) are currently available, with specific precautions and contraindications. We aim to resume the current indications for vaccines in the vulnerable populations to support flu vaccination inclusiveness, in anticipation of a "universal vaccine" strategy.
nov-2020
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/38 - PEDIATRIA GENERALE E SPECIALISTICA
English
asthma
children
immunodeficiency
influenza vaccine
pregnancy
universal vaccine
Sgrulletti, M., Ottaviano, G., Sangerardi, M., Chini, L., Dellepiane, R.m., Martire, B., et al. (2020). One step closer to influenza vaccine inclusiveness. PEDIATRIC ALLERGY AND IMMUNOLOGY, 31(S26), 69-71 [10.1111/pai.13338].
Sgrulletti, M; Ottaviano, G; Sangerardi, M; Chini, L; Dellepiane, Rm; Martire, B; Montin, D; Rizzo, C; Moschese, V
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
PAI-31-69.pdf

solo utenti autorizzati

Licenza: Copyright dell'editore
Dimensione 207.48 kB
Formato Adobe PDF
207.48 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/262872
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 0
social impact